93 64 (Rabeprazole Sodium Delayed-Release 20 mg)
Pill with imprint 93 64 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Teva Pharmaceuticals USA Inc..
Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 64
- 93 64
- 20 mg
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00093-0064||Teva Pharmaceuticals USA, Inc.|
Related Images for "93 64"
More about rabeprazole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 71 Reviews
- Drug class: proton pump inhibitors
- FDA Alerts (3)
- Patient Information
- Rabeprazole (Advanced Reading)
- Rabeprazole Delayed-Release Tablets
- Rabeprazole Sprinkle Capsules
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.